Skip to main content

Schizophrenia & Psychotic Disorders

Schizophrenia & Psychotic Disorders
The suicide rate among people with schizophrenia spectrum disorders is 170 times higher than in the general population, according to a study published online in the journal Schizophrenia Research.
Coping During COVID-19
In this video, psychiatrist Richard Jackson, MD, speaks about assessing and monitoring tardive dyskinesia during telepsychiatry visits.
Coping During COVID-19
In this video, Leslie Citrome, MD, MPH, details 5 steps to success for clinicians treating patients who have tardive dyskinesia or are at risk of the disorder.
Coping During COVID-19
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, offers guidance on the proper treatment of tardive dyskinesia (TD) during the COVID-19 pandemic.
Coping During COVID-19
A “small but important” number of people will develop COVID-19–related psychosis, according to a rapid review published online in Schizophrenia Research.
Schizophrenia & Psychotic Disorders
Patients who switched from risperidone to lurasidone experienced reductions in several adverse effects, proportionate to increases experienced while on risperidone, according to a study in BMC Psychiatry.
Schizophrenia & Psychotic Disorders
Patients with an acute exacerbation of schizophrenia who received an investigational antipsychotic drug had significantly greater improvement in the PANSS total score, compared with those who received placebo, according to a published study.
Schizophrenia & Psychotic Disorders
An analysis of brain scans from more than 300 patients suggests two distinct neuroanatomical subtypes of schizophrenia. Researchers published the findings online in the journal Brain.
Schizophrenia & Psychotic Disorders
Sustained use of the antipsychotic olanzapine in patients with remitted psychotic depression was associated with a thinning of the cortex, when compared with placebo, according to a study published online in JAMA Psychiatry.
Bipolar Disorders
In this video, Christoph U. Correll, MD, of Hofstra/Northwell in New York, discusses the possible clinical applications of the combination of olanzapine and the mu-opioid antagonist samidorphan.
Bipolar Disorders
In this video, Christoph U. Correll, MD, discusses additional research needed on the combination of olanzapine and the mu-opioid antagonist samidorphan.
Back to Top